Given the potential pathogenetic differences between C9orf72 HREs with reduced and increased expression, the role of ATXN2 in C9orf72 HRE carriers warrants reevaluation in ALS patients lacking C9orf72 HREs [69]. Here, C9orf72 is linked to amyotrophic lateral sclerosis.